Increased plasma prolactin levels in a group of men with breast cancer - a preliminary study
(1990) In Anticancer research 10(1). p.59-62- Abstract
Gonadal and hypophyseal hormones were investigated in 15 males with breast cancer and 15 tumour referents, on average 1 month postoperatively. Plasma prolactin was found to be significantly more often elevated in men with breast cancer compared with referents (p <0.005). Another group of men with breast cancer disclosed a tendency for lower S-FSH levels compared with the referents (p <0.01). No significant difference was seen between cases and referents regarding S-LH, p-estradiol or p-testosterone. The size of the primary breast tumour was correlated with a higher prolactin level. The findings lend support to a theory implicating prolactin and possibly prolactinomas as a risk factor for the disease in males.
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/6d0d5920-f0a0-4df9-bf96-de6f1d84753b
- author
- Olsson, H. LU ; Alm, P. LU ; Aspegren, K. ; Gullberg, B. LU ; Jonsson, P. E. and Ranstam, J.
- organization
- publishing date
- 1990-01-01
- type
- Contribution to journal
- publication status
- published
- keywords
- breast cancer, men, plasma, prolactin
- in
- Anticancer research
- volume
- 10
- issue
- 1
- pages
- 59 - 62
- publisher
- International Institute of Cancer Research
- external identifiers
-
- scopus:0025264065
- pmid:2110433
- ISSN
- 0250-7005
- language
- English
- LU publication?
- yes
- id
- 6d0d5920-f0a0-4df9-bf96-de6f1d84753b
- date added to LUP
- 2018-12-19 13:44:03
- date last changed
- 2024-01-15 10:23:02
@article{6d0d5920-f0a0-4df9-bf96-de6f1d84753b, abstract = {{<p>Gonadal and hypophyseal hormones were investigated in 15 males with breast cancer and 15 tumour referents, on average 1 month postoperatively. Plasma prolactin was found to be significantly more often elevated in men with breast cancer compared with referents (p <0.005). Another group of men with breast cancer disclosed a tendency for lower S-FSH levels compared with the referents (p <0.01). No significant difference was seen between cases and referents regarding S-LH, p-estradiol or p-testosterone. The size of the primary breast tumour was correlated with a higher prolactin level. The findings lend support to a theory implicating prolactin and possibly prolactinomas as a risk factor for the disease in males.</p>}}, author = {{Olsson, H. and Alm, P. and Aspegren, K. and Gullberg, B. and Jonsson, P. E. and Ranstam, J.}}, issn = {{0250-7005}}, keywords = {{breast cancer; men; plasma; prolactin}}, language = {{eng}}, month = {{01}}, number = {{1}}, pages = {{59--62}}, publisher = {{International Institute of Cancer Research}}, series = {{Anticancer research}}, title = {{Increased plasma prolactin levels in a group of men with breast cancer - a preliminary study}}, volume = {{10}}, year = {{1990}}, }